Literature DB >> 12419383

Understanding the unique mechanism of L-FMAU (clevudine) against hepatitis B virus: molecular dynamics studies.

Youhoon Chong1, Chung K Chu.   

Abstract

The molecular dynamics simulation of HBV-polymerase.DNA.L-FMAU-TP complex demonstrated that L-FMAU-TP may not serve as a substrate for HBV polymerase because the appropriate binding of L-FMAU-TP to the active site of HBV polymerase may not take place without the unfavorable conformational adjustment, which prevents L-FMAU-TP from being incorporated into the growing viral DNA chain.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12419383     DOI: 10.1016/s0960-894x(02)00747-3

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  9 in total

Review 1.  Role of Marine Natural Products in the Genesis of Antiviral Agents.

Authors:  Vedanjali Gogineni; Raymond F Schinazi; Mark T Hamann
Journal:  Chem Rev       Date:  2015-08-28       Impact factor: 60.622

2.  Synthesis and anti-HIV activity of D- and L-thietanose nucleosides.

Authors:  Hyunah Choo; Xin Chen; Vikas Yadav; Jianing Wang; Raymond F Schinazi; Chung K Chu
Journal:  J Med Chem       Date:  2006-03-09       Impact factor: 7.446

Review 3.  Novel approaches towards conquering hepatitis B virus infection.

Authors:  Guo-Yi Wu; Hong-Song Chen
Journal:  World J Gastroenterol       Date:  2007-02-14       Impact factor: 5.742

4.  Computational model of hepatitis B virus DNA polymerase: molecular dynamics and docking to understand resistant mutations.

Authors:  Pankaj R Daga; Jinsong Duan; Robert J Doerksen
Journal:  Protein Sci       Date:  2010-04       Impact factor: 6.725

5.  Predicting target-ligand interactions with graph convolutional networks for interpretable pharmaceutical discovery.

Authors:  Paola Ruiz Puentes; Laura Rueda-Gensini; Natalia Valderrama; Isabela Hernández; Cristina González; Laura Daza; Carolina Muñoz-Camargo; Juan C Cruz; Pablo Arbeláez
Journal:  Sci Rep       Date:  2022-05-19       Impact factor: 4.996

6.  Understanding the molecular basis of HBV drug resistance by molecular modeling.

Authors:  Ashoke Sharon; Chung K Chu
Journal:  Antiviral Res       Date:  2008-08-31       Impact factor: 5.970

7.  Noncompetitive inhibition of hepatitis B virus reverse transcriptase protein priming and DNA synthesis by the nucleoside analog clevudine.

Authors:  Scott A Jones; Eisuke Murakami; William Delaney; Phillip Furman; Jianming Hu
Journal:  Antimicrob Agents Chemother       Date:  2013-06-17       Impact factor: 5.191

Review 8.  Hepatitis B virus reverse transcriptase - Target of current antiviral therapy and future drug development.

Authors:  Daniel N Clark; Jianming Hu
Journal:  Antiviral Res       Date:  2015-09-25       Impact factor: 5.970

9.  Evaluation of 2'-deoxy-2'-[18F]fluoro-5-methyl-1-beta-L: -arabinofuranosyluracil ([18F]-L: -FMAU) as a PET imaging agent for cellular proliferation: comparison with [18F]-D: -FMAU and [18F]FLT.

Authors:  Ryuichi Nishii; Andrei Y Volgin; Osama Mawlawi; Uday Mukhopadhyay; Ashutosh Pal; William Bornmann; Juri G Gelovani; Mian M Alauddin
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-12-04       Impact factor: 9.236

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.